Our UK Manufacturing
Sterile injectable products manufactured to GMP* Guidelines
Products made in the UK
Our comprehensive UK manufacturing plant in Wrexham is responsible for the manufacture of some of our sterile injectable products. Our facility is approved by the MHRA**. Our UK Sterile facility is also audited and approved by other highly accredited Global regulatory bodies. The UK manufacturing site operates as C.P. Pharmaceuticals, which is a subsidiary of Wockhardt Bio AG
A wide range of injectable products
CP Pharmaceuticals Ltd and Wockhardt UK have several decades of experience in manufacturing a wide spectrum of sterile injectable products.
Our sterile injectable products cover a wide range of therapy areas including insulin for diabetes, heparin for anticoagulation and also pain management. Our products are available in many forms, including cartridges, vials and ampoules. We manufacture liquid or lyophilised (dry powder) products, in a range of fill sizes.
*Good Manufacturing Practice is that part of quality assurance which ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorisation (MA) or product specification. GMP is concerned with both production and quality control
**Medicines and Healthcare Products Regulatory Agency